Advanced Breast Cancer Female

2 clinical trials · Condition

Record	Firm	Date
Palbociclib Plus Letrozole For Postmenopausal Women With HR(+) HER2(-) Advanced Breast Cancer For Whom Letrozole Is Deemed Appropriate (NCT02600923)	Pfizer	2016-04-15
Expanded Access Study Of Palbociclib (PD-0332991) In Combination With Letrozole As Treatment Of Post-Menopausal Women With HR-Positive, Her2-Negative Advanced Breast Cancer For Whom Letrozole Therapy Is Deemed Appropriate (NCT02142868)	Pfizer

Every clearance here is in the API, with alerts when new ones post.